<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/8319F78A-DCBD-49F6-BE00-78E1CD75CDA9"><gtr:id>8319F78A-DCBD-49F6-BE00-78E1CD75CDA9</gtr:id><gtr:name>University of York</gtr:name><gtr:department>Biology</gtr:department><gtr:address><gtr:line1>Heslington</gtr:line1><gtr:line4>York</gtr:line4><gtr:line5>North Yorkshire</gtr:line5><gtr:postCode>YO10 5DD</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/8319F78A-DCBD-49F6-BE00-78E1CD75CDA9"><gtr:id>8319F78A-DCBD-49F6-BE00-78E1CD75CDA9</gtr:id><gtr:name>University of York</gtr:name><gtr:address><gtr:line1>Heslington</gtr:line1><gtr:line4>York</gtr:line4><gtr:line5>North Yorkshire</gtr:line5><gtr:postCode>YO10 5DD</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/798CB33D-C79E-4578-83F2-72606407192C"><gtr:id>798CB33D-C79E-4578-83F2-72606407192C</gtr:id><gtr:name>EPSRC</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:line4>Swindon</gtr:line4><gtr:line5>Wiltshire</gtr:line5><gtr:postCode>SN2 1ET</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>CO_FUNDER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6735E1B5-078A-4BFE-A4A7-07C687B4788E"><gtr:id>6735E1B5-078A-4BFE-A4A7-07C687B4788E</gtr:id><gtr:name>Croda</gtr:name><gtr:address><gtr:line1>Foundry Lane</gtr:line1><gtr:line2>Ditton</gtr:line2><gtr:postCode>WA8 8UB</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/CF7F58C1-4B26-4CBA-9FE8-BA1DD8457CB7"><gtr:id>CF7F58C1-4B26-4CBA-9FE8-BA1DD8457CB7</gtr:id><gtr:name>Unilever UK Central Resources Ltd</gtr:name><gtr:address><gtr:line1>Quarry Road East</gtr:line1><gtr:line2>Bebington</gtr:line2><gtr:postCode>CH63 3JW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5B9542CC-D7F0-45DA-A423-16458386EA25"><gtr:id>5B9542CC-D7F0-45DA-A423-16458386EA25</gtr:id><gtr:name>GlaxoSmithKline PLC</gtr:name><gtr:address><gtr:line1>Park Road</gtr:line1><gtr:postCode>SG12 0DP</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/21701621-358A-4514-AD54-E5C69F2C8CDF"><gtr:id>21701621-358A-4514-AD54-E5C69F2C8CDF</gtr:id><gtr:firstName>Margaret</gtr:firstName><gtr:otherNames>Caroline</gtr:otherNames><gtr:surname>Smith</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/40961896-62ED-4B6F-ADD4-E56CE94315D6"><gtr:id>40961896-62ED-4B6F-ADD4-E56CE94315D6</gtr:id><gtr:firstName>Ian</gtr:firstName><gtr:otherNames>Alexander</gtr:otherNames><gtr:surname>Graham</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/9797E05E-1346-476C-9005-6FF51EC92D3B"><gtr:id>9797E05E-1346-476C-9005-6FF51EC92D3B</gtr:id><gtr:firstName>Andrew</gtr:firstName><gtr:otherNames>John</gtr:otherNames><gtr:surname>King</gtr:surname><gtr:roles><gtr:role><gtr:name>RESEARCHER_COI</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BB%2FM018210%2F1"><gtr:id>BF38B62E-EBC6-4534-BB0F-EBDABBBB6036</gtr:id><gtr:title>Developing platforms for the production of diterpenoids (TSB application reference 43970-304155)</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/M018210/1</gtr:grantReference><gtr:abstractText>Plants produce a wide range of diterpenoids, many of which are used commercially such as a paclitaxel, employed in the treatment of cancers, and steviol glyclosides which are used as zero-calorie natural sweeteners. Many other useful diterpenoids cannot yet be commercially exploited due to their limited availability and/or high production costs. Using synthetic biology it is now possible to engineer organisms such as yeast so that they are able to convert simple sugars to high-value chemicals. This project will develop yeast, algae and higher plant species as &amp;quot;chassis organisms&amp;quot; which can be used for the scalable production of diterpenoids. Our project will focus in particular on compounds which could be used in the treatment of cancers, or used in skin products such as sunscreens to protect skin against harmful UV light. These biological production systems will also be useful in producing many other diterpenoids that are found in nature.</gtr:abstractText><gtr:technicalSummary>The project will address issues of supply and high production costs of selected high value chemicals of particular interest to its industrial partners (GSK, Unilever and Croda) and will provide advances in technology for wider applications across UK research and industry. 

Currently a number of plant diterpenoids are used in the pharmaceutical, agricultural, food additive and fragrance industries. These are sourced from a limited number of species, restricting their supply and greatly increasing their cost. Using synthetic biology and metabolic engineering, the project will develop new production systems for high value diterpenoids by exploiting recent gene-based discoveries and novel platforms developed by the academic partner laboratories. 

The aim of this project is to develop scalable heterologous production systems for diterpenoids. First, &amp;quot;chassis organisms&amp;quot; will be constructed that can supply elevated levels of the common diterpenoid precursor geranylgeranyl pyrophosphate. Genes for secondary metabolism will then be introduced into these chassis to create strains producing specific target compounds. We will then scale up laboratory production processes to pilot scale (eg 100 litre fermenter) and develop processes for the purification of the target compounds. Although we will focus primarily on specific diterpenoids of interest to the industrial partners within our consortium, the GGPP producing chassis will be universal in that they could also be adapted to produce a wider range of diterpenoids of interest to the pharmaceutical, personal care, food, fragrance and agricultural industries.

The overall team has a very good balance of 'push and pull' and is well placed academically, technically and commercially to deliver a high impact project for the IB Catalyst.</gtr:technicalSummary><gtr:potentialImpactText>As described in the proposal submitted to TSB.</gtr:potentialImpactText><gtr:fund><gtr:end>2020-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2015-04-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>2397565</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Invited Special Seminar given by Professor Ian Graham at the University of Melbourne, Australia</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>7787A50D-9E08-41C9-8F58-97AB4F0D83EE</gtr:id><gtr:impact>Professor Ian Graham gave an invited Special Seminar at the Molecular Science &amp;amp; Biotechnology Institute at the University of Melbourne, Australia. His talk was titled 'Molecular breeding of medicinal crops and discoveries along the way'.</gtr:impact><gtr:outcomeId>58beb09c948243.21694440</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.bio21.unimelb.edu.au/professor-ian-graham-presents-molecular-breeding-medicinal-crops-and-discoveries-along-way</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Poster at the Chemistry and Biology of Natural Products Symposium X, University of Warwick, 30 June - 1 July 2016.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>76B4CB55-EF8F-4B5C-8D71-FD4BD161D6C5</gtr:id><gtr:impact>The CBNP X was a two-day symposium for postgraduate students, PDRAs and young academics but also open to any academic/industrialist working in any areas of natural product chemistry and biology.</gtr:impact><gtr:outcomeId>58ad67dd95edf5.40344151</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>Not applicable this year - project began recently.</gtr:description><gtr:id>6F72DCA7-C15F-4097-A08D-1EC0CF2ED102</gtr:id><gtr:impactTypes><gtr:impactType>Economic</gtr:impactType></gtr:impactTypes><gtr:outcomeId>56d83af42d0404.65297114</gtr:outcomeId><gtr:sector>Agriculture, Food and Drink,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>Good progress has been made towards the key objectives of the project. Since we began in April 2015 work has focussed on making chassis organisms which can produce the precursor compound (geranylgeranyl pyrophosphate) of the diterpenoid target molecules. This project is a collaborative work, and the chassis organisms being developed include yeast (Maggie Smith at University of York), algae (Alison Smith at University of Cambridge) and plants (Ian Graham, project PI). 

A set of molecular tools has been collected which will be useful in the optimisation of geranylgeranyl pyrophosphate (GGPP). The project is now developing new production systems for plant, yeast and algal-based production of GGPP, aiming to transfer multiple gene constructs to enable production of this important precursor, we hope to conclude this work within the next year. The plant work is being carried out in Ian Graham's Group, the yeast work in Maggie Smith's Group and Alison Smith's Group is developing the new algal strains. 

In parallel, the diterpenoid biosynethesis gene clusters have been investigated. This has led to the discovery of a gene cluster from Jatropha curcas. This cluster contains the genes that encode the enzymes required to convert geranylgeranyl pyrophosphate into a number of diterpenoids including the lathyranes jolkinol C and epi-jolkinol C. The conversion of casbene to the lathyranes involves an intramolecular carbon-carbon ring closure (this work was done in collaboration with Geoff Brown, University of Reading). This conversion of casbene to lathyranes will allow the scalable heterologous production of these potential anti-cancer drugs, which can often only be sourced in limited quantities from their native plant.</gtr:description><gtr:exploitationPathways>Not applicable this year - project at early stage.</gtr:exploitationPathways><gtr:id>8EAFA4D2-F344-4BA7-848B-D8A0F064E74D</gtr:id><gtr:outcomeId>56a77cbd4f0353.22535174</gtr:outcomeId><gtr:sectors><gtr:sector>Agriculture, Food and Drink,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>5DA08B42-CE15-4737-873E-FE7CA63389FA</gtr:id><gtr:title>A Cytochrome P450-Mediated Intramolecular Carbon-Carbon Ring Closure in the Biosynthesis of Multidrug-Resistance-Reversing Lathyrane Diterpenoids.</gtr:title><gtr:parentPublicationTitle>Chembiochem : a European journal of chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0e706d78d513ca5e64c3fb1e8f6773b1"><gtr:id>0e706d78d513ca5e64c3fb1e8f6773b1</gtr:id><gtr:otherNames>King AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1439-4227</gtr:issn><gtr:outcomeId>58a47c1bd87dc3.07600182</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/M018210/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>17F21DBC-4946-4262-AD07-9914F6EA12F7</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Bioengineering</gtr:text></gtr:researchSubject><gtr:researchSubject><gtr:id>C23BE70F-1EF6-4CC7-88B0-841CB18DD875</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Genetics &amp; development</gtr:text></gtr:researchSubject><gtr:researchSubject><gtr:id>13975896-2E87-4DAA-99BC-E8D86B00B146</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Plant &amp; crop science</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>18D298A9-FFE3-432F-B077-E3B703272E29</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Biochemical engineering</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>19C5179C-0522-47E8-82DA-48583B56264E</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Metabolic engineering</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>5BDC9422-9331-418B-8192-152BC0EB055E</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Microbial</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>0CB3E3B8-1C4E-4DEB-89C2-D9CDF3586F5E</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Novel industrial products</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>15080F45-1EA3-41B4-BC23-C49CB918FBC4</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Plant physiology</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>